Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats
BMC Pharmacology and Toxicology · 2024
DOI: 10.1186/s40360-024-00809-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Pharmacology and Toxicology, 2024. Verfasst von Elaf R Alaasam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Alsadar Medical City, Directorate of Najaf Health, Najaf, Iraq. Hauptthemen laut MEDLINE: Reperfusion Injury, Resveratrol, Rats, Sprague-Dawley, Kidney. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Private Universität Witten/Herdecke gGmbH.
Abstract (Originalsprache)
Background
Renal ischemia-reperfusion injury (IRI) is a significant contributor to renal dysfunction, acute kidney injury (AKI), and associated morbidity and mortality. Resveratrol, a polyphenol and phytoalexin, is known for its anti-inflammatory, antioxidant, and anti-cancer properties. This study investigates the nephroprotective potential of resveratrol in a rat model of renal IRI. Materials and methods Twenty-eight male Sprague-Dawley rats were divided into four groups: Sham , IRI , DMSO , and Resveratrol . The Sham group underwent identical procedures without renal pedicle clamping, while the IRI group experienced 30 min of ischemia followed by 2 h of reperfusion. The DMSO group received dimethyl sulfoxide (DMSO) intraperitoneally 30 min before ischemia, and the Resveratrol group received 30 mg/kg resveratrol intraperitoneally 30 min before ischemia. Biochemical parameters (Urea, creatinine, IL-1β, NF-κβ, SOD, GSH, Bcl-2, and caspase-3) and histopathological changes were assessed.
Results
IRI caused a substantial increase in serum creatinine, Urea, IL-1β, NF-κβ, and caspase-3 levels, while simultaneously decreasing SOD, GSH, and Bcl-2 levels. Resveratrol treatment mitigated these effects by lowering inflammatory and apoptotic markers, enhancing antioxidant defenses, and improving histological outcomes.
Conclusion
Resveratrol demonstrates significant nephroprotective effects in renal IRI, primarily through its antioxidant, anti-inflammatory, and anti-apoptotic properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Alsadar Medical City, Directorate of Najaf Health, Najaf, Iraq.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Kufa, Najaf, Iraq.
- Department of Internal Medicine, Faculty of Medicine, University of Kufa, Najaf, Iraq.
- Department of Pathology and Forensic Medicine, Faculty of Medicine, University of Kufa, Najaf, Iraq.
- Department of Pharmacology and Therapeutics, Faculty of Pharmacy, University of Kufa, Najaf, Iraq.
- Department of Research & Development, Funogen, Athens, 11741, Greece, Attiki.
Förderung
- Private Universität Witten/Herdecke gGmbH
Zitieren
APA
Alaasam, E. R., Janabi, A. M., Al-Buthabhak, K. M., Almudhafar, R. H., Hadi, N. R., Alexiou, A., Papadakis, M., Abo-El Fetoh, M. E., Fouad, D., & El-Saber Batiha, G. (2024). Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-024-00809-8
Vancouver
Alaasam ER, Janabi AM, Al-Buthabhak KM, Almudhafar RH, Hadi NR, Alexiou A, et al. Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats. BMC Pharmacology and Toxicology. 2024. doi:10.1186/s40360-024-00809-8
BibTeX
@article{Alaasam2024,
author = {Alaasam, Elaf R and Janabi, Ali M and Al-Buthabhak, Karrar M and Almudhafar, Rihab H and Hadi, Najah R and Alexiou, Athanasios and Papadakis, Marios and Abo-El Fetoh, Mohammed E and Fouad, Dalia and El-Saber Batiha, Gaber},
title = {Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats},
journal = {BMC Pharmacology and Toxicology},
year = {2024},
doi = {10.1186/s40360-024-00809-8}
}
EUVIMED